Saxonov Serge 4
4 · 10x Genomics, Inc. · Filed Nov 25, 2025
Insider Transaction Report
Form 4
Saxonov Serge
DirectorChief Executive Officer
Transactions
- Sale
Class A Common Stock
2025-11-24$19.00/sh−13,261$251,936→ 1,021,556 total
Holdings
- 27(indirect: See footnote)
Class A Common Stock
- 213,250(indirect: See footnote)
Class A Common Stock
- 58,000(indirect: See footnote)
Class A Common Stock
Footnotes (4)
- [F1]The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
- [F2]The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
- [F3]The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
- [F4]The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.